Propylparaben

Propylparaben

SCHEMBL276142

CCCOC(=O)c1ccc(O)cc1.OCCCCCl

nearest known ligand 0.71

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 4/20 0.71
▸ TSHR P16473 3/20 0.71
▸ ALDH1A1 P00352 3/20 0.71
▸ CHRM1 P11229 1/20 0.71
▸ SLC6A2 P23975 1/20 0.71
▸ KDR P35968 1/20 0.71
▸ TDP1 Q9NUW8 1/20 0.71
▸ LMNA P02545 3/20 0.63
▸ SMN1; SMN2 Q16637 3/20 0.63
▸ CYP1A2 P05177 2/20 0.63
▸ CYP2C19 P33261 2/20 0.63
▸ CYP2D6 P10635 2/20 0.63
▸ MAPK1 P28482 2/20 0.63
▸ NR1H2 P55055 1/20 0.63
▸ RNASEL Q05823 1/20 0.63
▸ ESR2 Q92731 2/20 0.53
▸ CA12 O43570 1/20 0.53
▸ CA1 P00915 1/20 0.53
▸ CA2 P00918 1/20 0.53
▸ CA7 P43166 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cetyl Alcohol SCHEMBL9614341 0.88 ESR1 (0.76) ESR1TSHRALDH1A1CHRM1SLC6A2
Propylparaben SCHEMBL7200410 0.86 ESR1 (0.89) ESR1TSHRALDH1A1CHRM1SLC6A2
Propylparaben SCHEMBL6670652 0.86 ESR1 (0.89) ESR1TSHRALDH1A1CHRM1SLC6A2
Propylparaben SCHEMBL8102900 0.85 ESR1 (0.93) ESR1TSHRALDH1A1CHRM1SLC6A2
Propylparaben SCHEMBL429594 0.84 ESR1 (1.00) ESR1TSHRALDH1A1CHRM1SLC6A2
Propylparaben SCHEMBL977 0.84 ESR1 (1.00) ESR1TSHRALDH1A1CHRM1SLC6A2
Propylparaben SCHEMBL27533588 0.83 ESR1 (0.89) ESR1TSHRALDH1A1CHRM1SLC6A2
SCHEMBL10930012 0.83 ESR1 (0.67) ESR1TSHRALDH1A1CHRM1SLC6A2
Propylparaben SCHEMBL9406450 0.83 ESR1 (0.96) ESR1TSHRALDH1A1CHRM1SLC6A2
Propylparaben SCHEMBL1010568 0.83 ESR1 (0.96) ESR1TSHRALDH1A1CHRM1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8133877-B2 Composition comprising an antisense sequence implicated in the regulation of angiogenesis GENE SIGNAL INTERNATIONAL SA (CH) 2012-03-13 — — US claimed
US-7803906-B2 Composition comprising an angiogenesis related protein GENE SIGNAL INTERNATIONAL SA (CH) 2010-09-28 — — US claimed
US-20160304617-A1 5T4-TARGETED IMMUNOFUSION MOLECULE AND METHODS ASANA BIOSCIENCES, LLC (US) 2016-10-20 — — US disclosed
EP-3010939-A2 5T4-TARGETED IMMUNOFUSION MOLECULE AND METHODS Asana BioSciences, LLC (US) 2016-04-27 — — EP disclosed
WO-2014204988-A2 5T4-TARGETED IMMUNOFUSION MOLECULE AND METHODS ASANA BIOSCIENCES, LLC (US) 2014-12-24 — — WO disclosed
US-8133877-B2 Composition comprising an antisense sequence implicated in the regulation of angiogenesis GENE SIGNAL INTERNATIONAL SA (CH) 2012-03-13 — — US disclosed
US-20110104169-A1 REGULATOR GENES OF ANGIOGENESIS, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND THEIR APPLICATIONS GENE SIGNAL INTERNATIONAL (CH) 2011-05-05 — — US disclosed
US-7803906-B2 Composition comprising an angiogenesis related protein GENE SIGNAL INTERNATIONAL SA (CH) 2010-09-28 — — US disclosed
US-20090264364-A1 GENES IMPLICATED IN THE REGULATION OF ANGIOGENESIS, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND THEIR APPLICATIONS GENE SIGNAL INTERNATIONAL, A CORPORATION OF SWITZERLAND (CH) 2009-10-22 — — US disclosed
US-7553492-B2 Gene overexpression/underexpression; antibodies; drug screening; kits GENE SIGNAL (FR) 2009-06-30 — — US disclosed
WO-2006055578-A2 ASYMMETRIC SYNTHESIS OF (-)-AGELASTATIN A TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEMS OF HIGHER EDUCATION (US) 2006-05-26 — — WO disclosed
US-20050153917-A1 Gene overexpression/underexpression; antibodies; drug screening; kits GENE SIGNAL, A CORPORATION OF FRANCE (FR) 2005-07-14 — — US disclosed
US-20050119215-A1 Regulator genes of angiogenesis, pharmaceutical preparations containing them and their applications GENE SIGNAL, A CORPORATION OF FRANCE (FR) 2005-06-02 — — US disclosed
Send feedback